Anesthetics News

Latest Pain / Anesthetics News From Medical News Today.

Total news: 25
Last news: August 30, 2007 19:00:00

Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects. The new study is published online in the The Journal of Experimental Medicine. [click link for full article] - [Read more]

A new US study showed that using hypnosis before breast cancer surgery led to patients reporting less pain and fewer unpleasant after effects and it saved hospital costs. Procedures took less time and the amount of anesthetic required was also reduced, said the authors of the study. [click link for full article] - [Read more]

Anesiva, Inc. (Nasdaq: ANSV) announced that it has completed enrollment of the Phase 3 clinical study of Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system to reduce pain associated with peripheral venous access procedures in adults. Zingo, a fast-acting topical, needle free system for local analgesia, was approved by the U.S. [click link for full article] - [Read more]

TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced that it has initiated a Phase I multiple dose clinical trial to evaluate the safety, tolerability and pharmacokinetics of tezampanel given as a subcutaneous injection to healthy male and female volunteers once-daily for four consecutive days. [click link for full article] - [Read more]

Diamyd Medical AB (http://www.omxgroup.com, ticker: DIAM B; http://www.otcqx.com, ticker DMYDY)Diamyd Medical announced today that NP2, the companys first drug candidate in its nerve targeting drug delivery system (NTDDS) gene therapy platform, will be the subject of a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration on August 29, 2007. [click link for full article] - [Read more]

Jennie Ching-I Tsao, associate professor of pediatrics in the Pediatric Pain Program at Mattel Childrens Hospital UCLA, has been selected as one of six winners of the 2007-08 Mayday Pain & Society Fellowship.Established in 2003, the fellowship provides leaders in the pain-management field with the tools and skills to advocate for better treatment for pain. Fellows learn how to better communicate with media and policymakers and to raise the visibility of their issues. [click link for full article] - [Read more]

New data suggest that patients with fibromyalgia treated with 60mg or 120mg of Cymbalta® (duloxetine HCl) experienced greater reduction in pain severity beginning one week after starting duloxetine than those taking placebo (sugar pill), as measured by the Brief Pain Inventory Average Pain Score (BPI). [click link for full article] - [Read more]

People with chronic, intractable back pain know exactly what they need relief directly where it hurts. Peripheral nerve field stimulation (PNFS), the newest weapon against back pain for people who are finding no relief from conventional treatment, does just that, says Dr. Eugene Lipov, who is Director of Research, Alexian Brothers Hospital Network Pain Program. [click link for full article] - [Read more]

An estimated 43 million people age 18 and older - almost one-fifth of the adult population of the United States - reported taking aspirin regularly, that is every day or every other day, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Aspirin, a medicine that relieves pain and reduces fever, can also help lower the risk of heart attack, blood clot-related strokes, and other blood circulation problems in people who have these conditions. [click link for full article] - [Read more]

As children head back to school, they may be expanding their minds but there is a good chance theyre also damaging their bodies. Back pain, historically an adult affliction, is now becoming common among school-aged children and studies show a direct correlation between backpacks and back pain in children. [click link for full article] - [Read more]

Organon, the human healthcare business unit of Akzo Nobel (Euronext Amsterdam: AKZ), announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved rocuronium bromide, its neuromuscular blocking agent (NMBA) for use during general anesthesia, under the brand name Eslax. [click link for full article] - [Read more]

For the first time, pain researchers at Washington University School of Medicine in St. Louis have shown that its possible to separate the good effects of opiate drugs such as morphine (pain relief) from the unwanted side effects of those drugs (tolerance, abuse and addiction).The investigators, led by Zhou-Feng Chen, Ph.D. [click link for full article] - [Read more]

A new guideline to improve the diagnosis and management of chronic fatigue syndrome/ myalgic encephalomyelitis (or encephalopathy) (CFS/ME) in adults and children was launched yesterday 22 August. CFS/ME is a relatively common illness, affecting an estimated 193,000 people. The condition can be disabling, involving a complex range of symptoms, the most common being fatigue, but including headaches, sleep disturbance and muscle pain. [click link for full article] - [Read more]

Actavis Group, the international generic pharmaceuticals company, announced that it has received approval from the U.S. Food & Drug Administration to market Fentanyl Transdermal System. Distribution of the product will begin immediately. Fentanyl Transdermal System is the generic equivalent of Alza/Janssens Duragesic(R) and available in 25, 50, 75 and 100 mcg/hour strengths. [click link for full article] - [Read more]

New data suggest that patients with fibromyalgia treated with 60mg or 120mg of Cymbalta(R) (duloxetine HCl) experienced greater reduction in pain severity beginning one week after starting duloxetine than those taking placebo (sugar pill), as measured by the Brief Pain Inventory Average Pain Score (BPI). [click link for full article] - [Read more]

According to a new Associated Press analysis of federal drug prescription data, retail sales of five leading painkillers nearly doubled from 1997 to 2005, reflecting a surge in use by patients nationwide who are living in pain. In light of this provocative information, patients may wish to consider the benefits of a physical therapists intervention for pain relief from certain chronic conditions, says the American Physical Therapy Association (APTA). [click link for full article] - [Read more]

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for fentanyl transdermal system in the 25, 50, 75 & 100 mcg/hour strengths. [click link for full article] - [Read more]

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Hydrocodone Bitartrate and Acetaminophen Tablets USP, 7.5 mg/750 mg, 10 mg/500 mg, 5 mg/500 mg, and 10 mg/325 mg strengths. The Office of Generic Drugs, U.S. [click link for full article] - [Read more]

According to a recent analysis by the Associated Press (AP) news agency of figures from the US Drug Enforcement Administration (DEA), Americans are using painkillers more than ever before. Between 1997 and 2007 the volume of five major painkillers sold and distributed in the United States by hospitals, retail pharmacies, doctors and teaching centres has risen by 90 per cent. [click link for full article] - [Read more]

Advances in pain and palliative care for adults have been significant in the past decade due in part to increased recognition, support and use by caregivers and patients. While acknowledging that lessons from adults can be borrowed to help pediatric patients, an international team of pediatric palliative care specialists is also calling for increased research to address childrens differing physical, psycho-social and clinical needs. [click link for full article] - [Read more]